MGP
BMY icon

Metis Global Partners’s Bristol-Myers Squibb BMY Stock Holding History

Metis Global Partners’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.7M Sell
94,004
-6,591
-7% -$384K 0.14% 119
2025
Q4 		$5.43M Sell
100,595
-7,145
-7% -$344K 0.13% 133
2025
Q3 		$4.86M Sell
107,740
-7,866
-7% -$367K 0.11% 155
2025
Q2 		$5.35M Sell
115,606
-7,119
-6% -$349K 0.14% 135
2025
Q1 		$7.48M Buy
122,725
+16,222
+15% +$946K 0.21% 85
2024
Q4 		$6.02M Buy
106,503
+5,859
+6% +$327K 0.18% 91
2024
Q3 		$5.21M Buy
100,644
+4,687
+5% +$220K 0.16% 109
2024
Q2 		$3.99M Sell
95,957
-21,043
-18% -$942K 0.14% 124
2024
Q1 		$6.34M Sell
117,000
-2,251
-2% -$115K 0.23% 69
2023
Q4 		$6.12M Buy
119,251
+17,479
+17% +$918K 0.24% 64
2023
Q3 		$5.91M Buy
101,772
+13,122
+15% +$804K 0.29% 61
2023
Q2 		$5.67M Sell
88,650
-496
-0.6% -$33.3K 0.31% 56
2023
Q1 		$6.18M Buy
89,146
+22,128
+33% +$1.56M 0.4% 48
2022
Q4 		$4.82M Buy
67,018
+28,364
+73% +$2.14M 0.43% 45
2022
Q3 		$2.75M Buy
38,654
+1,846
+5% +$134K 0.44% 42
2022
Q2 		$2.83M Buy
36,808
+1,839
+5% +$140K 0.45% 42
2022
Q1 		$2.55M Buy
34,969
+15,607
+81% +$1.05M 0.31% 62
2021
Q4 		$1.21M Buy
+19,362
New +$1.14M 0.34% 65

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Metis Global Partners's BMY Position: Q1 2026 in Review

Metis Global Partners reduced its Bristol-Myers Squibb (BMY) stake by 6.6% in Q1 2026, selling an estimated $384K and leaving 94,004 shares worth $5.7M. The position accounts for 0.14% of the portfolio, ranked #119.

Metis Global Partners first reported a position in BMY in Q4 2021 and has held it in 18 quarters since. The position peaked at $7.48M in Q1 2025. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Metis Global Partners held 94,004 shares of Bristol-Myers Squibb worth $5.7M as of Q1 2026.
  • Metis Global Partners sold 6,591 Bristol-Myers Squibb shares in Q1 2026, an estimated $384K.
  • Bristol-Myers Squibb made up 0.14% of Metis Global Partners's portfolio in Q1 2026, its #119 holding.
  • Metis Global Partners first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 18 quarters since.
  • Metis Global Partners's Bristol-Myers Squibb position peaked at $7.48M in Q1 2025.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Metis Global Partners's 13F filing for Q1 2026, filed 7 May 2026.